Format

Send to

Choose Destination
See comment in PubMed Commons below
Leukemia. 2014 Oct;28(10):2104-6. doi: 10.1038/leu.2014.184. Epub 2014 Jun 6.

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma.

Author information

1
1] Grup de Recerca Clínica Aplicada en Neoplàsies Hematològiques-Hospital del Mar-IMIM, Barcelona, Spain [2] Universitat Autònoma de Barcelona, Barcelona, Spain.
2
1] Grup de Recerca Clínica Aplicada en Neoplàsies Hematològiques-Hospital del Mar-IMIM, Barcelona, Spain [2] Department of Pathology, Hospital del Mar-IMIM, Barcelona, Spain [3] Universitat Pompeu Fabra, Barcelona, Spain.
3
Department of Pathology, Hospital del Mar-IMIM, Barcelona, Spain.
4
1] Grup de Recerca Clínica Aplicada en Neoplàsies Hematològiques-Hospital del Mar-IMIM, Barcelona, Spain [2] Department of Hematology, Hospital del Mar-IMIM, Barcelona, Spain.
PMID:
24903481
DOI:
10.1038/leu.2014.184
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center